Yahoo Finance

Phlow Corp. Selected by the U.S. Food and Drug Administration Commissioner’s First-Ever National Priority Voucher Pilot Program to Advance Manufacturing of a Critical ...

RICHMOND, Va, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that the active ...
STAT

Phlow CEO speaks out on criticism of his record, plans for a drug ingredient stockpile, and a huge government contract

Earlier this week, the U.S. government awarded a $354 million contract to a new public benefit company called Phlow to make generics that are in short supply during the pandemic. The move, which is ...
Yahoo Finance

Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

Richmond, Virginia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today ...
Business Wire

Phlow Corp. and USP Announce Strategic Alliance Focused on Pharmaceutical Continuous Manufacturing to Increase Supply of Essential Medicines for U.S. Patients

RICHMOND, Va.--(BUSINESS WIRE)--Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a strategic alliance to develop a new ...
MarketWatch

Phlow Corp. Appoints Dawn Von Rohr as Chief Operating Officer to Advance Domestic Pharmaceutical Manufacturing

The MarketWatch News Department was not involved in the creation of this content. Richmond, Virginia, March 18, 2026 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American advanced pharmaceutical ...
Business Wire

Phlow Included in BARDA Contract Development and Manufacturing Organization Network to Provide Domestic API Capability for Essential Medicines and Medical Countermeasures

RICHMOND, Va.--(BUSINESS WIRE)--Phlow Corp., a U.S.-based essential medicines impact company, today announced that it has been approved for inclusion in the Biomedical Advanced Research and ...
FiercePharma

Phlow reaps $36M in series B fundraising to boost CDMO program

Medicine supply company Phlow plans to use $36 million in series B fundraising to continue expanding its CDMO business, dubbed cdmoX, to meet industry demands. (Max Zolotukhin/Getty Images) Phlow, a ...
FiercePharma

Phlow and nonprofit USP team to open drug development and manufacturing lab

Phlow, a Virginia-based CDMO, has teamed with the nonprofit U.S. Pharmacopeia (USP) to open a new drug development lab to focus on research and development of new drugs and advanced manufacturing ...